title: Reply: Diabetes Mellitus and Its Effects on All-Cause Mortality After Radiopeptide Therapy for Neuroendocrine Tumors: Methodologic Issues.
authors.forename: Maria
authors.initials: M
authors.lastname: Umlauft
authors.forename: Piotr
authors.initials: P
authors.lastname: Radojewski
authors.forename: Petar-Marko
authors.initials: PM
authors.lastname: Spanjol
authors.forename: Rebecca
authors.initials: R
authors.lastname: Dumont
authors.forename: Nicolas
authors.initials: N
authors.lastname: Marincek
authors.forename: Attila
authors.initials: A
authors.lastname: Kollar
authors.forename: Philippe
authors.initials: P
authors.lastname: Brunner
authors.forename: Jan
authors.initials: J
authors.lastname: Beyersmann
authors.forename: Jan
authors.initials: J
authors.lastname: Müller-Brand
authors.forename: Helmut R
authors.initials: HR
authors.lastname: Maecke
authors.forename: Markus
authors.initials: M
authors.lastname: Laimer
authors.affiliation: The University Hospital of Bern Freiburgstrasse 4 CH-3010 Bern, Switzerland E-mail: m.a.walter@gmx.net.
authors.forename: Martin A
authors.initials: MA
authors.lastname: Walter
mesh_terms: D003920:Diabetes Mellitus; D006801:Humans; D018358:Neuroendocrine Tumors